Zobrazeno 1 - 10
of 235
pro vyhledávání: '"Scott D Berkowitz"'
Autor:
Josephine Harrington, Anne S. Hellkamp, Kenneth W. Mahaffey, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Daniel E. Singer, Shaun G. Goodman, Manesh R. Patel, Jonathan P. Piccini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 11 (2024)
Background Days alive out of hospital (DAOH) is an objective and patient‐centered net benefit end point. There are no assessments of DAOH in clinical trials of interventions for atrial fibrillation (AF), and it is not known whether this end point i
Externí odkaz:
https://doaj.org/article/a5fb44f1354d4d29a8e3aab8c544798b
Publikováno v:
Frontiers in Pharmacology, Vol 4 (2013)
Direct oral anticoagulants that target a single coagulation factor (such as factor Xa or thrombin) have been developed in recent years in an attempt to address some of the limitations of traditional anticoagulants. Rivaroxaban is an oral, direct fact
Externí odkaz:
https://doaj.org/article/fa290693700b4764b4eb003d25f39ff9
Autor:
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M. Bauersachs, Scott D. Berkowitz, Lloyd Haskell, Elliot S. Barnathan, Marc P. Bonaca
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 8 (2024)
Background The VOYAGER PAD (Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
Externí odkaz:
https://doaj.org/article/cb7732979fc142828382971a3178e404
Autor:
Francis E. Ugowe, MD, Anne S. Hellkamp, MS, Allen Wang, BS, Richard C. Becker, MD, Scott D. Berkowitz, MD, Günter Breithardt, MD, Keith A.A. Fox, MB ChB, Jonathan L. Halperin, MD, Graeme J. Hankey, MD, Kenneth W. Mahaffey, MD, Christopher C. Nessel, MD, Daniel E. Singer, MD, Manesh R. Patel, MD, Jonathan P. Piccini, MD, MHS, FHRS
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 3, Pp 215-222 (2021)
Background: Insulin use may be a better predictor of stroke risk and morbidity and mortality than diabetes in patients with atrial fibrillation (AF). Objectives: Determine if the increased risk of stroke observed in patients with AF and diabetes is r
Externí odkaz:
https://doaj.org/article/6a0db23014864b818546be226fa651ca
Autor:
Connie N. Hess, Iris Baumgartner, Sonia S. Anand, Mark R. Nehler, Manesh R. Patel, E. Sebastian Debus, Michael Szarek, Warren Capell, Eva Muehlhofer, Scott D. Berkowitz, Lloyd P. Haskell, Rupert M. Bauersachs, Marc P. Bonaca, Judith Hsia
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 12 (2022)
Background Despite high female prevalence of peripheral artery disease (PAD), little is known about sex‐based outcomes after lower extremity revascularization (LER) for symptomatic PAD. The effects of rivaroxaban according to sex following LER have
Externí odkaz:
https://doaj.org/article/e206edcaf2794bc898a22f84d5fb18a2
Autor:
Mario Enrico Canonico, Raffaele Piccolo, Marisa Avvedimento, Attilio Leone, Salvatore Esposito, Anna Franzone, Giuseppe Giugliano, Giuseppe Gargiulo, Connie N. Hess, Scott D. Berkowitz, Judith Hsia, Plinio Cirillo, Giovanni Esposito, Marc P. Bonaca
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 4, p 164 (2023)
Patients with peripheral artery disease (PAD) are at an increased risk of major adverse cardiovascular events, and those with disease in the lower extremities are at risk of major adverse limb events primarily driven by atherothrombosis. Traditionall
Externí odkaz:
https://doaj.org/article/7f11cb4f21d846c59ef41f11ab56eddb
Autor:
Anthony P. Carnicelli, Anne S. Hellkamp, Kenneth W. Mahaffey, Daniel E. Singer, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Robert M. Califf, Manesh R. Patel
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 19 (2021)
Background In event‐driven clinical trials, study termination is based on accrual of a target number of primary efficacy events. For noninferiority trials in which superiority is conditionally examined, the ideal cohort in which to track event accr
Externí odkaz:
https://doaj.org/article/775fd7c4e9564bab97ecb1aeeaaa5927
Autor:
Alexander Solms, Matthias Frede, Scott D. Berkowitz, Anne Hermanowski‐Vosatka, Dagmar Kubitza, Wolfgang Mueck, Theodore E. Spiro, Stefan Willmann, Xiaoyu Yan, Liping Zhang, Dirk Garmann
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 11, Pp 805-814 (2019)
Prothrombin time (PT) is a measure of coagulation status and was assessed in the majority of patients in the rivaroxaban phase II and III clinical trials as a pharmacodynamic marker. In the absence of sufficient phase III pharmacokinetic (PK) data to
Externí odkaz:
https://doaj.org/article/3284b20cca0648198b411dd0ffa0f05c
Autor:
Anthonie W. A. Lensing, Christoph Male, Guy Young, Dagmar Kubitza, Gili Kenet, M. Patricia Massicotte, Anthony Chan, Angelo C. Molinari, Ulrike Nowak-Goettl, Ákos F. Pap, Ivet Adalbo, William T. Smith, Amy Mason, Kirstin Thelen, Scott D. Berkowitz, Mark Crowther, Stephan Schmidt, Victoria Price, Martin H. Prins, Paul Monagle
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-11 (2018)
Abstract Background Venous thromboembolism (VTE) is a relatively rare condition in childhood with treatment mainly based on extrapolation from studies in adults. Therefore, clinical trials of anticoagulation in children require novel approaches to de
Externí odkaz:
https://doaj.org/article/b6a58605a3f245d0935f0be64bd90cdc
Autor:
Anthony Chan, Anthonie W. A. Lensing, Dagmar Kubitza, Grahaem Brown, Dolores Elorza, Marta Ybarra, Jacqueline Halton, Sebastian Grunt, Gili Kenet, Damien Bonnet, Amparo Santamaria, Paola Saracco, Tina Biss, Francesco Climent, Philip Connor, Joseph Palumbo, Kirstin Thelen, William T. Smith, Amy Mason, Ivet Adalbo, Scott D. Berkowitz, Eva Hurst, Jeroen van Kesteren, Guy Young, Paul Monagle
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Venous thromboembolism (VTE) in young children is not well documented. Methods Clinicians from 12 institutions retrospectively evaluated the presentation, therapeutic management, and outcome of VTE in children younger than 2 years
Externí odkaz:
https://doaj.org/article/7fec6cb3488a49e0a905b43294ad0ded